CONMED (CNMD) vs. Its Competitors Head-To-Head Comparison

CONMED (NASDAQ:CNMD – Get Rating) is one of 71 public companies in the “Electromedical equipment” industry, but how does it compare to its peers? We will compare CONMED to related businesses based on the strength of its analyst recommendations, risk, institutional ownership, profitability, earnings, valuation and dividends.

Volatility and Risk

CONMED has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, CONMED’s peers have a beta of 13.27, suggesting that their average stock price is 1,227% more volatile than the S&P 500.

Earnings and Valuation

This table compares CONMED and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
CONMED	$1.05 billion	-$80.58 million	-33.85
CONMED Competitors	$1.05 billion	$117.16 million	5.17

CONMED’s peers have higher revenue and earnings than CONMED. CONMED is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Dividends

CONMED pays an annual dividend of $0.80 per share and has a dividend yield of 0.8%. CONMED pays out -28.2% of its earnings in the form of a dividend. As a group, “Electromedical equipment” companies pay a dividend yield of 2.3% and pay out -326.3% of their earnings in the form of a dividend. CONMED lags its peers as a dividend stock, given its lower dividend yield and higher payout ratio.

Insider and Institutional Ownership

47.6% of shares of all “Electromedical equipment” companies are owned by institutional investors. 4.9% of CONMED shares are owned by company insiders. Comparatively, 12.4% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares CONMED and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CONMED	-7.71%	11.39%	3.94%
CONMED Competitors	-659.83%	-48.46%	-23.66%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for CONMED and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CONMED	0	0	0	0	N/A
CONMED Competitors	109	636	1773	79	2.70

As a group, “Electromedical equipment” companies have a potential upside of 69.44%. Given CONMED’s peers higher possible upside, analysts clearly believe CONMED has less favorable growth aspects than its peers.

Summary

CONMED peers beat CONMED on 9 of the 12 factors compared.

About CONMED

(Get Rating)

CONMED Corp. operates as a medical technology company, which engages in the development, manufacturing, and sale of surgical devices and related equipment. It operates through the United States, Europe, Middle East, and Africa, and Asia Pacific geographical segments. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.